The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia.
about
New concepts for an old problem: the diagnosis of endometrial hyperplasiaAbsolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.Theories of endometrial carcinogenesis: a multidisciplinary approach.Problems in the differential diagnosis of endometrial hyperplasia and carcinoma.Significance of concurrent endometrial cancer in women with a preoperative diagnosis of atypical endometrial hyperplasiaThe effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women.Role of progesterone in endometrial cancerLevonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial.Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapyHormone replacement therapy and the endometrium.Design and conduct of clinical trials in hormone replacement therapy.Problems of endometrial histology interpretation.Challenges in the gynecologic care of premenopausal women with breast cancer.Influence of AKT on progesterone action in endometrial diseases.Endometrial Carcinoma in a Young Woman: "30 is Not Immune".Progesterone supplement in pregnancy: an immunologic therapy?Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trialApplication of Immunohistochemistry and Molecular Diagnostics to Clinically Relevant Problems in Endometrial Cancer Bojana Djordjevic, Shannon Westin, Russell R. BroaddusEndometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapyProgestin therapy of complex endometrial hyperplasia with and without atypia.Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history.Management of endometrial precancers.The endometrial hyperplasias revisited.Progesterone receptor action in leiomyoma and endometrial cancer.Ultrasonographic endometrial thickness measurement is predictive for treatment response in simple endometrial hyperplasia without atypiaRelapse risk of endometrial hyperplasia after treatment with the levonorgestrel-impregnated intrauterine system or oral progestogens.Preinvasive lesions of the endometrium.Histology of the human endometrium: from birth to senescence.Conservative management of young patients with endometrial highly-differentiated adenocarcinoma.The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17beta-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma.Perimenopausal bleeding: Patterns, pathology, response to progestins and clinical outcome.HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia.Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature.Immunocytodiagnosis of atypical hyperplasia and endometrial carcinoma in post-menopausal women.The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium.Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia.Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: a prospective study.Comparing the Administration of Letrozole and Megestrol Acetate in the Treatment of Women with Simple Endometrial Hyperplasia without Atypia: A Randomized Clinical Trial.
P2860
Q28071864-D202BAF8-E4E4-4DF1-B58E-B9F69778EC9DQ33710581-EC5C03D1-3457-4CAE-90B4-F89B1E317ECCQ33886758-ECDBD595-0293-4FC6-9AB2-10500C36A980Q33886764-30D83E9C-3EBF-4224-BF51-CA3D0E6AAA5EQ33940386-5510B50D-A40F-4CAB-9B4D-70A904878BC9Q33955664-EF95A724-1573-40FE-923A-529717F525FCQ34095034-A2079CA0-F1EA-4332-9B6D-F6B881288A8EQ34140046-97646124-9E35-4917-8C41-EF7A4FBA92BEQ34173018-956A542E-96F8-4081-BB21-A676C0D3AEF0Q34263283-9829BE01-1DB4-455A-88F8-1F2195E23573Q34397332-421D57CD-E79F-4394-9E34-7843A02DDFBDQ34575167-9915BA6D-ED1D-42F9-9B28-8CE7B6C29F46Q34616059-02770F92-A260-4F4D-8E89-341CD634258BQ35617565-89E92A3E-CB83-4C4D-B7FE-A31F77C82423Q35840401-13DC564E-53B4-4A0A-8959-023DFAC316D7Q35918350-DAA30181-FCC9-4977-B671-C88E0118D843Q36608842-12399ECB-6F0E-4615-ADBF-B256A349D1FAQ36817480-014169E0-ADDE-4A76-9848-277ABB664DC7Q36841899-8E9592C8-18AC-4905-826F-28B5F2F9A5D3Q37041231-25467096-B95B-4256-AEF6-ACE1CDC63FF3Q37187921-D72C3833-2A21-4079-BDFD-1D69F0E69443Q37235846-7367853B-4C93-43D7-A39B-167665C6BFABQ37238537-F5342721-3E0F-4773-9621-096DC60CABDAQ37251777-FF63147F-E98E-42C9-8641-62EE0DAAE4C2Q37338412-14B9C300-22F9-464F-974F-A5BBEF869DC0Q37437341-47AB9959-E39F-4BAE-BEBE-D803363D117FQ37561800-DF2FE6BD-50FD-46D8-98DE-31F000CD3CBDQ37773944-C92B4B29-763C-433C-A389-3BC543A1C0ADQ37773954-61711779-D61D-4984-B9E2-C5ADD543E9FEQ37833620-051E73DA-3CB6-4D07-B316-B11D098B9F45Q38354048-337884D3-35F6-4357-AEC7-620E209CC01EQ39395322-3DC1CCFA-4C66-4A89-AA5A-A910D8B7E6E4Q41095997-BFEFCF52-7BB8-4042-9200-9A414B405270Q41331490-5A0AD33A-089C-4B30-89CA-ED9ED6502919Q42035590-569FCF77-7AD3-42F5-81C2-ECF591877740Q42639071-37AE847D-6A6F-40CC-BBEB-93B320BC9B18Q43424392-B38FE9B8-790A-492C-94B9-E44B1280D040Q46143774-D2EC8671-D99F-4E99-AE38-05038C95D8D2Q46383608-24113366-2732-4C92-A625-BEDD1AB40E36Q47407585-BBD27128-8473-4F31-8815-D181C725085C
P2860
The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
The biologic significance of c ...... eated endometrial hyperplasia.
@en
The biologic significance of c ...... eated endometrial hyperplasia.
@nl
type
label
The biologic significance of c ...... eated endometrial hyperplasia.
@en
The biologic significance of c ...... eated endometrial hyperplasia.
@nl
prefLabel
The biologic significance of c ...... eated endometrial hyperplasia.
@en
The biologic significance of c ...... eated endometrial hyperplasia.
@nl
P1476
The biologic significance of c ...... eated endometrial hyperplasia.
@en
P2093
P304
P356
10.1016/0002-9378(89)90103-8
P407
P577
1989-01-01T00:00:00Z